Impact of loss of high-molecular-weight von Willebrand factor multimers on blood loss after aortic valve replacement

被引:22
作者
Bolliger, D. [1 ]
Dell-Kuster, S. [1 ,2 ]
Seeberger, M. D. [1 ]
Tanaka, K. A. [3 ]
Gregor, M. [1 ]
Zenklusen, U. [1 ]
Tsakiris, D. A.
Filipovic, M. [1 ,4 ]
机构
[1] Univ Basel Hosp, Dept Anaesthesia & Intens Care Med, CH-4031 Basel, Switzerland
[2] Basel Inst Clin Epidemiol & Biostat, Basel, Switzerland
[3] Emory Univ, Sch Med, Dept Anesthesiol, Atlanta, GA 30322 USA
[4] Cantonal Hosp St Gallen, Inst Anaesthesiol, St Gallen, Switzerland
关键词
blood; transfusion; coagulation; surgery; cardiovascular; PLATELET-FUNCTION; NORMAL PLASMA; STENOSIS; DISEASE; SURGERY; AGGREGATION; AGGREGOMETRY; PROTEOLYSIS; MANAGEMENT; LEVEL;
D O I
10.1093/bja/aer512
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Severe aortic stenosis is associated with loss of the largest von Willebrand factor (vWF) multimers, which could affect primary haemostasis. We hypothesized that the altered multimer structure with the loss of the largest multimers increases postoperative bleeding in patients undergoing aortic valve replacement. We prospectively included 60 subjects with severe aortic stenosis. Before and after aortic valve replacement, vWF antigen, activity, and multimer structure were determined and platelet function was measured by impedance aggregometry. Blood loss from mediastinal drainage and the use of blood and haemostatic products were evaluated perioperatively. Before operation, the altered multimer structure was present in 48 subjects (80). Baseline characteristics and laboratory data were similar in all subjects. The median blood loss after 6 h was 250 (105400) and 145 (85240) ml in the groups with the altered and normal multimer structures, respectively (P0.182). After 24 h, the cumulative loss was 495 (270650) and 375 (310600) ml in the groups with the altered and normal multimer structures, respectively (P0.713). Multivariable analysis revealed no significant influence of multimer structure and platelet function on bleeding volumes after 6 and 24 h. After 24 h, there was no obvious difference in vWF antigen, activity, and multimer structure in subjects with and without the altered multimer structure before operation or in subjects with and without perioperative plasma transfusion. The altered vWF multimer structure before operation was not associated with increased bleeding after aortic valve replacement. Our findings might be explained by perioperative release of vWF and rapid recovery of the largest vWF multimers.
引用
收藏
页码:754 / 762
页数:9
相关论文
共 35 条
  • [1] ABILDGAARD CF, 1980, BLOOD, V56, P712
  • [2] Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: an in vitro model
    Bolliger, D.
    Szlam, F.
    Molinaro, R. J.
    Rahe-Meyer, N.
    Levy, J. H.
    Tanaka, K. A.
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 2009, 102 (06) : 793 - 799
  • [3] Pre-analytical effects of pneumatic tube transport on impedance platelet aggregometry
    Bolliger, Daniel
    Seeberger, Manfred D.
    Tanaka, Kenichi A.
    Dell-Kuster, Salome
    Gregor, Michael
    Zenklusen, Urs
    Grapow, Martin
    Tsakiris, Dimitrios A.
    Filipovic, Miodrag
    [J]. PLATELETS, 2009, 20 (07) : 458 - 465
  • [4] AN ELISA TEST FOR THE BINDING OF VONWILLEBRAND ANTIGEN TO COLLAGEN
    BROWN, JE
    BOSAK, JO
    [J]. THROMBOSIS RESEARCH, 1986, 43 (03) : 303 - 311
  • [5] BUDDE U, 1990, THROMB HAEMOSTASIS, V63, P312
  • [6] Aortic Stenosis and Acquired von Willebrand Disease: Lack of Association
    Carrasco, Esperanza
    Lopez, Rodrigo
    Rattalino, Marcos
    Lema, Guillermo
    Pereira, Jaime
    Canessa, Roberto
    Zalaquett, Ricardo
    Carvajal, Claudia
    Carrasco, Paulo
    [J]. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2011, 25 (04) : 615 - 618
  • [7] von Willebrand factor abnormalities in aortic valve stenosis: Pathophysiology and impact on bleeding
    Casonato, Alessandra
    Sponga, Sandro
    Pontara, Elena
    Cattini, Maria Grazia
    Basso, Cristina
    Thiene, Gaetano
    Cella, Giuseppe
    Daidone, Viviana
    Gerosa, Gino
    Pagnan, Antonio
    [J]. THROMBOSIS AND HAEMOSTASIS, 2011, 106 (01) : 58 - 66
  • [8] Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction
    Chassot, P.-G.
    Delabays, A.
    Spahn, D. R.
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 2007, 99 (03) : 316 - 328
  • [9] Gola W, 2010, CARDIOL J, V17, P330
  • [10] HEYDE EC, 1958, NEW ENGL J MED, V259, P196